Acute cardiotoxicity due to 5-fluorouracil: An underestimated toxicity;Cardiotossicita acuta da 5-fluorouracile: Una tossicita sottovalutata

Minerva Cardioangiologica

Volumn 47, Issue 7-8, 1999, Pages 269-273

  Bertolini, A ^a   Fiumano M ^a   Muffatti, A ^a   Pedroncelli, S ^a   Doria, A ^a   Codazzi, G ^a   Giustiniani, S ^a   Scarinci, A ^a   Redaelli, G ^a  

^a NONE

Author keywords

Fluorouracil adverse effects; Heart diseases etiology; Neoplasms drug therapy

Indexed keywords

FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CARDIOTOXICITY; CASE REPORT; DIARRHEA; ELECTROCARDIOGRAM; FOOT MALFORMATION; HAND MALFORMATION; HUMAN; STOMATITIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART; HEART DISEASE; MALE; MIDDLE AGED; MOUTH TUMOR; POSTOPERATIVE PERIOD; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; ELECTROCARDIOGRAPHY; FLUOROURACIL; HEART; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POSTOPERATIVE PERIOD;

EID: 0033163882     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. De Vita V, Hellman S, Rosenberg SA. Cancer, principles and practice in Oncology. 5th edition. Philadelphia: Lippincott, 1996.
2. Bonadonna G, Robustelli della Cuna G. Manuale di oncologia medica. V edizione. Milano: Masson, 1994.
3. Machover D, Schwarzenberg L, Goldschmidt E, Tourani JM, Michalski B, Hayat M et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: A pilot study. Cancer Treat Rep 1982;66:1803-7.
4. Meta-analysis Group In cancer. Efficacy of Intravenous continuos infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998;16:301-8.
5. Maiello E, Giotta F, Giuliani F, Naglieri E, Galetta D, Colucci G. Trattamento sequenziale con methotrexate e fluorouracile nel carcinoma colorettale in fase avanzata. Arg Oncol 1992;13:13-22.
6. Pazdur R, Bready B, Moore DF. Clinical trials of fluorouracil with alfa-interferon in advanced colorectal carcinomas. Semin Oncol 1991;18(5 Suppl 7):67-70.
7. Weh HJ, Wilke HJ, Dierlamm J, Klaassen U, Siegmund R, Illiger HJ et al. Weekly therapy with folinic acid (FA) and high-dose 5-fluorauracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma. Annal Oncol 1994;5:233-7.
8. Bonadonna G. Conceptual and practical advances in the management of breast cancer. Karnofsky Memorial Lecture. J Clin Oncol 1989;7:1380-97.
9. Al Sarraf M. Head and neck cancer: chemotherapy concepts. Semin Oncol 1988;15:70-85.
10. de Gramont A, Bosset C, Floquet A. A prospectively randomized trial comparing 5FU bolus with low dose folinic acid and 5FU bolus plus continuous infusion with high dose folinic acid for advanced colorectal cancer. Proc Am Soc Clin Oncol 1995;14:455 .
11. Ardalan B, Chua L, Tian E. A phase II study of weekly 24-hour infusion with higt-dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 1991;9: 625-30.
12. de Gramont A, Louvet C, Krulik M. The french experience with infusional 5-fluorouracil in advanced colorectal cancer. J Infusional Chemother 1996;6(3): 133-6.
13. Scheithauer W, Rosen H, Schiessel R. Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure L-isomer of leucovorin for the treatment of advanced colorectal cancer: randomized phase III study. J Clin Oncol 1997;15:908-14.
14. Scheithauer W, Rosen H, Schiessel R, Schuller J, Karall M, Ernst F et al. Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil and leucovorin. Cancer 1991; 67:1294-8.
15. Machover D, Goldschmidt E, Chollet P. Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high dose folinic acid. J Clin Oncol 1986,4:685-96.
16. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ et al. Levamisole and 5-FU for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
17. May D, Wandl U, Becher R, Niederle N, Schimidt CG. Cardiac side effects of 5-fluorouracil. Dtsch Med Wochenschrm 1990;115:618-21.
18. de Forni M, Malet-Martino MC, Jaillais P, Shubinski RE, Bachaud JM, Lemaire L et al. Cardiotoxicity of high-dose continuos infusion fluorouracil: a prospective clinical study. J Clin Oncol 1992;10:1795-801.
19. Mizuno Y, Hokamura Y, Kimura T, Kimura Y, Kaikita K, Yasue H. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction. Jpn Circ J 1995;59:303-7.
20. Grandi AM, Pinotti G, Morandi E, Zanzi P, Bulgheroni P, Guasti L. Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low dose of folinic acid: A one year follow-up study. Ann Oncol 1991;8:705-8.
21. Meyer CC, Calis KA, Burke LB, Walawander CA, Grasela THI. Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 1997;17:729-36.
22. Porta C, Moroni M, Ferrari S, Nastasi G. Endothelin-1 and 5-fluorouracil induced cardiotoxicity. Neoplasma 1998;45:81-2.
23. Schober C, Papageorgiou E, Harstrick A, Bokemeyer C, Mugge A, Stal M et al. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer 1993;72:2242-7.
24. Robben NC, Pippas AW, Moore JO. The syndrome of 5-fluorouracil cardiotoxicity. Cancer 1993;71:493-509.
25. Beretta A. Trattato delle malattie cardiovascolari. Torino: UTET, 1987.